West Pharma (WST) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
West Pharmaceutical Services deeply integrates its packaging systems into biologic drug development as early as the trial stages. The EV/EBITDA trend captures this success, where 29.94 shows the current value of the metric. A monopoly status in injectable packaging ensures a stable cash flow, while total robotization of production areas managed by AI maximizes operational efficiency.
Comprehensive metric breakdowns and analytics for West Pharmaceutical Services Inc (WST)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- company total debt and liquidity indicators:
Debt to Equity West Pharmaceutical Services|WST - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio West Pharma|WST - Company Aggregate Debts|Debt to Book Capitalization Ratio West Pharma|WST - Company Long-Term Liabilities|Company Short-Term Debts West Pharmaceutical Services|Quick Liquidity westpharma.com
- business earnings and investment ratios data:
WST - Company Profit|Future Profit West Pharmaceutical Services|WST - Market Price to Net Income Ratio|Future Price to Earnings West Pharma|WST - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio West Pharma|WST - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) West Pharmaceutical Services|WST - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months westpharma.com|WST - Expected net earnings per share growth this year|Expected earnings per share growth for next year West Pharmaceutical Services
- sales volume and revenue indicators:
Fundamental company analysis:WST (westpharma.com)
For a portfolio manager, this indicator serves as a filter between market euphoria and the actual value of assets. The dynamic EV/EBITDA value of the company compares the total enterprise value, including net debt, with operating profit before depreciation and amortization. By analyzing this chart, an investor determines the premium paid for cash flow generation. For West Pharmaceutical Services (WST), a high valuation is justified by the creation of a closed sealing ecosystem, where FDA certification makes switching suppliers critically expensive.
Competitors of West Pharmaceutical Services (WST)
Intuitive Surgical - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio danaher.com (DHR)|BDX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|STE (STERIS PLC) - Enterprise Value to Operating Income Before Depreciation|Baxter Healthcare (BAX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation MASI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization stevanatogroup.com|TFX (teleflex.com) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MMSI (Merit Medical Systems)|Enterprise Value to Operating Income Before Depreciation Ratio NVST|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ICU Medical Corp ICUI|Business Value to Operating Income Before Depreciation XRAY|LMAT: Enterprise Value to EBITDA Ratio|ATRC - EV/EBITDA Multiple|STAAR Surgical Co. (STAA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio ChromaDex Corp.|ZIMV (zimvie.com) - EV/EBITDA Multiple|Company Value to EBITDA AngioDynamics Inc. ANGO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerus (CERS)|Teknova - Enterprise Value to Operating Income Before Depreciation|Monogram Technologies - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio STSS (Sharps Technology, Inc.)|INFU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio Utah Medical Products UTMD|KORU Medical (KRMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation NYXH|MBOT (Microbot Medical, Inc.) - EV/EBITDA Multiple|PDEX: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek Ltd. (ZTEK)|EV/EBITDA Multiple Elutia Inc. (ELUT)|EV/EBITDA Multiple MLSS (Milestone Scientific Inc)|Enterprise Value to EBITDA Multiple NEXGEL, Inc.|Retractable Technologies, Inc. - EV/EBITDA Multiple|HBIO - EV/EBITDA Multiple|FEMY (femasys.com) - Enterprise Value to EBITDA Ratio|Meihua Medical (MHUA) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio POAI|CJMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ATRI|Enterprise Value to Operating Income Before Depreciation Ratio NURO
